Comparison of three α‐glucosidase inhibitors for glycemic control and bodyweight reduction in Japanese patients with obese type 2 diabetes

AIMS/INTRODUCTION: α‐Glucosidase inhibitors (αGIs) are widely used for the primary treatment of type 2 diabetes. We compared the clinical effects of three αGIs (miglitol, acarbose and voglibose) in patients with obese type 2 diabetes. MATERIALS AND METHODS: Japanese patients (n = 81) with obese type...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugihara, Hitoshi, Nagao, Mototsugu, Harada, Taro, Nakajima, Yasushi, Tanimura‐Inagaki, Kyoko, Okajima, Fumitaka, Tamura, Hideki, Inazawa, Takeshi, Otonari, Takatoshi, Kawakami, Masanobu, Oikawa, Shinichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley-Blackwell 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023585/
https://www.ncbi.nlm.nih.gov/pubmed/24843762
http://dx.doi.org/10.1111/jdi.12135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023585/
https://www.ncbi.nlm.nih.gov/pubmed/24843762
http://dx.doi.org/10.1111/jdi.12135

Ejemplares similares